Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
Completed · Phase 1
Conditions studied: Metastatic Cancer
In brief
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with liver metastases.
Key facts
- Study ID
- NCT00567970
- Run by
- Mayo Clinic
- People needed
- 9
- Starts
- 2007-04-02
- Expected to finish
- 2016-04-21
- Last updated by the study team
- 2018-10-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.